STO · H100.ST
H100 Group AB
SEK 2.03+SEK 0.08 (+3.89%)
H100 Group AB: Technology · Software - Application.
Loading market information…
XETRA · AJ91.DE · EUR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
DocCheck AG’s quoted price sits in the lower half of its reported 52-week range, 33.96% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
DocCheck AG’s forward annual dividend is €1.00 per share, paid annual. The forward yield is 9.52% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow DocCheck AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
DocCheck AG offers community, agency, and e-commerce services for the healthcare sector in Europe. The company develops and implements communication strategies for media on healthcare and business-to-business sectors; sells medical supplies and medical technology primarily via mail order to various medical professional groups, and invests in healthcare sectors, as well as involved in online advertising, market research, online studies, and paid content for healthcare market players. It also operates platform for information exchange, online services, and e-commerce in this market. DocCheck AG was founded in 1990 and is based in Cologne, Germany.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SEK 2.03+SEK 0.08 (+3.89%)
H100 Group AB: Technology · Software - Application.
€525.00+€5.00 (+0.96%)
LIMES Schlosskliniken AG’s quoted price sits in the upper half of its reported 52-week range, 11.76% below the high.
€28.40+€0.20 (+0.71%)
MPH Health Care AG’s quoted price sits in the upper half of its reported 52-week range, 4.38% below the high.
€11.00€0.00 (0.0%)
Apontis Pharma AG’s quoted price sits in the lower half of its reported 52-week range, 10.93% below the high.
€2.78+€0.22 (+8.59%)
BRAIN Biotech AG’s quoted price sits in the lower half of its reported 52-week range, 28.53% below the high.
€2.79€0.00 (0.0%)
FamiCord AG’s quoted price sits in the lower half of its reported 52-week range, 60.98% below the high.
€20.20+€0.20 (+1.0%)
MeVis Medical Solutions AG’s quoted price sits in the lower half of its reported 52-week range, 24.63% below the high.
€0.92+€0.08 (+9.58%)
Maternus-Kliniken AG’s quoted price sits in the lower half of its reported 52-week range, 91.61% below the high.
